Aberdeen Asset Management’s St Jude Medical STJ Stock Holding History
Bought
Maintained
Sold
Other funds holding STJ
FPF
JWA
AIM
Aberdeen Asset Management's STJ Position: Q1 2017 in Review
Aberdeen Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 59,942 shares — an estimated $4.81M sold.
Aberdeen Asset Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $15.9M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.
- Aberdeen Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
- Aberdeen Asset Management sold 59,942 St Jude Medical shares in Q1 2017, an estimated $4.81M.
- Aberdeen Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
- Aberdeen Asset Management's St Jude Medical position peaked at $15.9M in Q2 2014.
- 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.
Based on Aberdeen Asset Management's 13F filing for Q1 2017, filed 10 May 2017.